Balance Therapeutics is a clinical-stage pharmaceutical company that provides therapies to treat debilitating neurological conditions. It develops BTD-001, a small molecule GABA (gamma-aminobutyric acid) antagonist that can be used for the treatment of excessive daytime sleepiness in idiopathic hypersomnia and narcolepsy type 2 as well as for cognitive impairment in Down syndrome.